How to Help Your Patients Find Intuniv in Stock: A Provider's Guide

As the stimulant ADHD medication shortage continues into 2026, more providers are prescribing Intuniv (guanfacine extended-release) as either a primary treatment or an adjunctive therapy. Along with this increased prescribing comes increased frequency of pharmacy calls and messages from patients and families who can't fill their prescriptions. This guide provides your practice with actionable strategies — from proactive patient communication to clinical workarounds — to minimize treatment interruptions.

Why This Is Happening in 2026

Intuniv is not officially in shortage in the U.S. in 2026. As a non-controlled substance, it is not subject to DEA production quotas that have restricted stimulant supply. However, localized pharmacy-level stockouts are occurring due to:

• Demand displacement from the stimulant shortage driving new non-stimulant prescriptions
• Growing adjunct use alongside stimulant medications
• Generic market fragmentation — pharmacies stock only one manufacturer's version
• Dose-specific gaps, particularly for 3 mg and 4 mg strengths

Strategy 1: Write for Generic by Strength and Form (Not Brand)

Writing prescriptions for "guanfacine ER" rather than "Intuniv" allows pharmacists to dispense any FDA-approved generic equivalent. Since multiple manufacturers produce guanfacine ER, this simple step significantly expands the number of pharmacies that can fill the prescription — and may lower cost for the patient as well.

All FDA-approved generic guanfacine ER formulations must demonstrate bioequivalence to brand Intuniv, so clinical efficacy should be comparable.

Strategy 2: Prescribe 90-Day Supply via Mail Order

Because guanfacine ER is not a controlled substance, mail-order pharmacy is a viable option with no legal restrictions. A 90-day supply prescription gives patients a buffer against local pharmacy stockouts and often comes with lower copays through insurance.

For newly diagnosed patients or those changing doses, consider a 30-day supply initially with a 90-day refill prescription sent to mail-order once the dose is confirmed.

Strategy 3: Direct Patients to Specific Pharmacy Types

When a patient's usual pharmacy is out of stock, provide specific guidance on where to look next:

• Independent pharmacies: Often source from different wholesalers than major chains (CVS, Walgreens, Rite Aid) and may have stock when chains are out.
• Grocery store pharmacies: Kroger, Publix, Safeway, HEB — often have separate supply chains from standalone pharmacy chains.
• Hospital outpatient pharmacies: If your patient is seen in a hospital-affiliated clinic, the hospital's outpatient pharmacy may have better access.

Strategy 4: Use medfinder for Pharmacy Lookup

Rather than asking your staff to call pharmacies, direct patients to medfinder. medfinder calls pharmacies near the patient to check which ones can fill the prescription. Results are texted to the patient — reducing administrative burden on your office while keeping patients in treatment.

Strategy 5: Proactively Counsel Patients on Not Stopping Abruptly

At every visit, remind families that Intuniv cannot be stopped suddenly. Suggested language to use or include in after-visit summaries:

"If your pharmacy is ever out of Intuniv, call us before you run out of pills. Do not skip doses or stop on your own — this medication needs to be tapered slowly to keep blood pressure stable. Contact us with at least 3-5 days of medication remaining."

Strategy 6: Have a Clinical Backup Plan Ready

For patients where Intuniv stockouts are a recurring problem, document your alternative plan in the chart so it can be executed quickly if needed. The most commonly used alternatives include:

• Clonidine ER (Kapvay): Same drug class; twice-daily dosing; generally more sedating; no established dose equivalence — start low and titrate.
• Atomoxetine (Strattera): Different mechanism (NE reuptake inhibitor); takes 4-8 weeks for full effect; FDA-approved for children, adolescents, and adults; also non-controlled.

Documentation and Refill Management Tips

• Send electronic prescriptions with the note "generic guanfacine ER acceptable" to maximize dispensing flexibility
• Flag patients on Intuniv in your EHR for proactive outreach during refill periods
• Consider writing a 30-day supply with three refills so patients have their full year supply authorized and can fill early without scheduling issues

Bottom Line

Intuniv's non-controlled status gives you more flexibility than stimulant prescriptions — mail-order, early refills, and generic substitution are all viable options. The key is proactive communication and a documented backup plan. For a clinical briefing on Intuniv availability, see Intuniv Shortage: What Providers Need to Know. To direct patients to medfinder's pharmacy search, visit medfinder for providers.